Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments (Annals of Hematology, (2020), 99, 2, (277-282), 10.1007/s00277-019-03893-7)

Bari A.
Marcheselli R.
Sacchi S.
Re A.
Pagani C.
Tucci A.
Botto B.
Vitolo U.
Molinari A. L.
Puccini B.
Pulsoni A.
Santoro A.
Tani M.
Nassi L.
Meli E.
Pavone V.
Bonfichi M.
Evangelista A.
Gioia D.
Levis A.
Zinzani P.

January 2021

In the article entitled “The classic prognostic factors in advanced Hodgkin’s lymphoma patients are ...

Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9)

April 2022

open12noAcknowledgements: This work was supported in part by Rigenerand srl and by Associazione Sost...

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Schaule, J.
Kroeze, S.G.C.
Blanck, O.
Stera, S.
Kahl, K.H.
Roeder, F.
Combs, S.E.
Kaul, D.
Claes, A.
Schymalla, M.M.
Adebahr, S.
Eckert, F.
Lohaus, F.
Abbasi-Senger, N.
Henke, G.
Szuecs, M.
Geier, M.
Sundahl, N.
Buergy, D.
Dummer, R.
Guckenberger, M.

January 2020

An amendment to this paper has been published and can be accessed via the original article

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Valpione, Sara
Mundra, Piyushkumar A.
Galvani, Elena
Campana, Luca G.
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

July 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...

Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Dave, Rajiv V.
Kim, Baek
Courtney, Alona
O’Connell, Rachel
Rattay, Tim
Taxiarchi, Vicky P.
Kirkham, Jamie J.
Camacho, Elizabeth M.
Fairbrother, Patricia
Sharma, Nisha
Cartlidge, Christopher W. J.
Horgan, Kieran
McIntosh, Stuart A.
Leff, Daniel R.
Vidya, Raghavan
Potter, Shelley
Holcombe, Chris
Copson, Ellen
Coles, Charlotte E.
Cutress, Ramsey I.
Gandhi, Ashu
Kirwan, Cliona C.

September 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-06-08, online 2021-06-23...

Correction to: Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop (Journal for ImmunoTherapy of Cancer (2020) 7 (131) DOI: 10.1186/s40425-019-0602-4)

Bedognetti D.
Ceccarelli M.
Galluzzi L.
Lu R.
Palucka K.
Samayoa J.
Spranger S.
Warren S.
Wong K. -K.
Ziv E.
Chowell D.
Coussens L. M.
De Carvalho D. D.
Denardo D. G.
Galon J.
Kaufman H. L.
Kirchhoff T.
Lotze M. T.
Luke J. J.
Minn A. J.
Politi K.
Shultz L. D.
Simon R.
Thorsson V.
Weidhaas J. B.
Ascierto M. L.
Ascierto P. A.
Barnes J. M.
Barsan V.
Bommareddy P. K.
Bot A.
Church S. E.
Ciliberto G.
De Maria A.
Draganov D.
Ho W. S.
McGee H. M.
Monette A.
Murphy J. F.
Nistico P.
Park W.
Patel M.
Quigley M.
Radvanyi L.
Raftopoulos H.
Rudqvist N. -P.
Snyder A.
Sweis R. F.
Valpione S.
Zappasodi R.
Butterfield L. H.
Disis M. L.
Fox B. A.
Cesano A.
Marincola F. M.

January 2019

Following publication of the original article [1], the author reported that an author name, Roberta ...

Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

Hawarden, Amy
Russell, Bryn
Gee, Mary Ellen
Kayali, Fatima
Clamp, Andrew
Crosbie, Emma Jayne
Edmondson, Richard John

May 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-05-17, pub-electronic 20...

Correction to: CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi, B.O.
Dumauthioz, N.
Marti, B.
Zhang, L.
Lanitis, E.
Irving, M.
Schneider, P.
Mach, J.P.
Coukos, G.
Romero, P.
Donda, A.

January 2018

After publication of this article [1], it was noticed that 3 authors were missed from the author lis...

Correction to: CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi, B.O.
Dumauthioz, N.
Marti, B.
Zhang, L.
Lanitis, E.
Irving, M.
Schneider, P.
Mach, J.P.
Coukos, G.
Romero, P.
Donda, A.

January 2018

After publication of this article [1], it was noticed that 3 authors were missed from the author lis...

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

Femel, Julia
van Hooren, Luuk
Herre, Melanie
Cedervall, Jessica
Saupe, Falk
Huijbers, Elisabeth J. M.
Verboogen, Danielle R. J.
Reichel, Matthias
Thijssen, Victor L.
Griffioen, Arjan W.
Hellman, Lars
Dimberg, Anna
Olsson, Anna-Karin

October 2022

The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and red...

Publisher Correction: Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration.

Clapes, Thomas
Polyzou, Aikaterini
Prater, Pia
Sagar
Morales-Hernández, Antonio
Ferrarini, Mariana Galvao
Kehrer, Natalie
Lefkopoulos, Stylianos
Bergo, Veronica
Hummel, Barbara
Obier, Nadine
Maticzka, Daniel
Bridgeman, Anne
Herman, Josip S
Ilik, Ibrahim
Klaeylé, Lhéanna
Rehwinkel, Jan
McKinney-Freeman, Shannon
Backofen, Rolf
Akhtar, Asifa
Cabezas-Wallscheid, Nina
Sawarkar, Ritwick
Rebollo, Rita
Grün, Dominic
Trompouki, Eirini

January 2022

Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265Funder: Max...

Author Correction: Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation (Nature Immunology, (2019), 20, 3, (288-300), 10.1038/s41590-018-0298-5)

Zundler, Sebastian
Becker, Emily
Spocinska, Marta
Slawik, Monique
Parga-Vidal, Loreto
Stark, Regina
Wiendl, Maximilian
Atreya, Raja
Rath, Timo
Leppkes, Moritz
Hildner, Kai
López-Posadas, Rocío
Lukassen, S. ren
Ekici, Arif B.
Neufert, Clemens
Atreya, Imke
van Gisbergen, Klaas P. J. M.
Neurath, Markus F.

January 2019

In the version of this article initially published, a portion of the Acknowledgements section (“the ...

Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.

Taieb, Julien
Rivera, Fernando
Siena, Salvatore
Karthaus, Meinolf
Valladares-Ayerbes, Manuel
Gallego, Javier
Geissler, Michael
Koukakis, Reija
Demonty, Gaston
Peeters, Marc

January 2018

The authors would like to include the following changes in the published article

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells (Scientific Reports, (2017), 7, 1, (5898), 10.1038/s41598-017-05859-z)

AlShamaileh, H
Wang, T
Xiang, D
Yin, W
Tran, Ha Lien Phuong
Barrero, RA
Zhang, PZ
Li, Y
Kong, Lingxue
Liu, K
Zhou, SF
Hou, Y
Shigdar, Sarah
Duan, Wei

December 2020

An amendment to this paper has been published and can be accessed via a link at the top of the paper...

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments (Annals of Hematology, (2020), 99, 2, (277-282), 10.1007/s00277-019-03893-7)

Bari A.
Marcheselli R.
Sacchi S.
Re A.
Pagani C.
Tucci A.
Botto B.
Vitolo U.
Molinari A. L.
Puccini B.
Pulsoni A.
Santoro A.
Tani M.
Nassi L.
Meli E.
Pavone V.
Bonfichi M.
Evangelista A.
Gioia D.
Levis A.
Zinzani P.

January 2021

In the article entitled “The classic prognostic factors in advanced Hodgkin’s lymphoma patients are ...

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments (Annals of Hematology, (2020), 99, 2, (277-282), 10.1007/s00277-019-03893-7)

Bari A.
Marcheselli R.
Sacchi S.
Re A.
Pagani C.
Tucci A.
Botto B.
Vitolo U.
Molinari A. L.
Puccini B.
Pulsoni A.
Santoro A.
Tani M.
Nassi L.
Meli E.
Pavone V.
Bonfichi M.
Evangelista A.
Gioia D.
Levis A.
Zinzani P.

January 2021

In the article entitled “The classic prognostic factors in advanced Hodgkin’s lymphoma patients are ...

Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9)

April 2022

open12noAcknowledgements: This work was supported in part by Rigenerand srl and by Associazione Sost...

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Schaule, J.
Kroeze, S.G.C.
Blanck, O.
Stera, S.
Kahl, K.H.
Roeder, F.
Combs, S.E.
Kaul, D.
Claes, A.
Schymalla, M.M.
Adebahr, S.
Eckert, F.
Lohaus, F.
Abbasi-Senger, N.
Henke, G.
Szuecs, M.
Geier, M.
Sundahl, N.
Buergy, D.
Dummer, R.
Guckenberger, M.

January 2020

An amendment to this paper has been published and can be accessed via the original article

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Valpione, Sara
Mundra, Piyushkumar A.
Galvani, Elena
Campana, Luca G.
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

July 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...

Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Dave, Rajiv V.
Kim, Baek
Courtney, Alona
O’Connell, Rachel
Rattay, Tim
Taxiarchi, Vicky P.
Kirkham, Jamie J.
Camacho, Elizabeth M.
Fairbrother, Patricia
Sharma, Nisha
Cartlidge, Christopher W. J.
Horgan, Kieran
McIntosh, Stuart A.
Leff, Daniel R.
Vidya, Raghavan
Potter, Shelley
Holcombe, Chris
Copson, Ellen
Coles, Charlotte E.
Cutress, Ramsey I.
Gandhi, Ashu
Kirwan, Cliona C.

September 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-06-08, online 2021-06-23...

Correction to: Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop (Journal for ImmunoTherapy of Cancer (2020) 7 (131) DOI: 10.1186/s40425-019-0602-4)

Bedognetti D.
Ceccarelli M.
Galluzzi L.
Lu R.
Palucka K.
Samayoa J.
Spranger S.
Warren S.
Wong K. -K.
Ziv E.
Chowell D.
Coussens L. M.
De Carvalho D. D.
Denardo D. G.
Galon J.
Kaufman H. L.
Kirchhoff T.
Lotze M. T.
Luke J. J.
Minn A. J.
Politi K.
Shultz L. D.
Simon R.
Thorsson V.
Weidhaas J. B.
Ascierto M. L.
Ascierto P. A.
Barnes J. M.
Barsan V.
Bommareddy P. K.
Bot A.
Church S. E.
Ciliberto G.
De Maria A.
Draganov D.
Ho W. S.
McGee H. M.
Monette A.
Murphy J. F.
Nistico P.
Park W.
Patel M.
Quigley M.
Radvanyi L.
Raftopoulos H.
Rudqvist N. -P.
Snyder A.
Sweis R. F.
Valpione S.
Zappasodi R.
Butterfield L. H.
Disis M. L.
Fox B. A.
Cesano A.
Marincola F. M.

January 2019

Following publication of the original article [1], the author reported that an author name, Roberta ...

Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

Hawarden, Amy
Russell, Bryn
Gee, Mary Ellen
Kayali, Fatima
Clamp, Andrew
Crosbie, Emma Jayne
Edmondson, Richard John

May 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-05-17, pub-electronic 20...

Correction to: CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi, B.O.
Dumauthioz, N.
Marti, B.
Zhang, L.
Lanitis, E.
Irving, M.
Schneider, P.
Mach, J.P.
Coukos, G.
Romero, P.
Donda, A.

January 2018

After publication of this article [1], it was noticed that 3 authors were missed from the author lis...

Correction to: CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi, B.O.
Dumauthioz, N.
Marti, B.
Zhang, L.
Lanitis, E.
Irving, M.
Schneider, P.
Mach, J.P.
Coukos, G.
Romero, P.
Donda, A.

January 2018

After publication of this article [1], it was noticed that 3 authors were missed from the author lis...

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

Femel, Julia
van Hooren, Luuk
Herre, Melanie
Cedervall, Jessica
Saupe, Falk
Huijbers, Elisabeth J. M.
Verboogen, Danielle R. J.
Reichel, Matthias
Thijssen, Victor L.
Griffioen, Arjan W.
Hellman, Lars
Dimberg, Anna
Olsson, Anna-Karin

October 2022

The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and red...

Publisher Correction: Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration.

Clapes, Thomas
Polyzou, Aikaterini
Prater, Pia
Sagar
Morales-Hernández, Antonio
Ferrarini, Mariana Galvao
Kehrer, Natalie
Lefkopoulos, Stylianos
Bergo, Veronica
Hummel, Barbara
Obier, Nadine
Maticzka, Daniel
Bridgeman, Anne
Herman, Josip S
Ilik, Ibrahim
Klaeylé, Lhéanna
Rehwinkel, Jan
McKinney-Freeman, Shannon
Backofen, Rolf
Akhtar, Asifa
Cabezas-Wallscheid, Nina
Sawarkar, Ritwick
Rebollo, Rita
Grün, Dominic
Trompouki, Eirini

January 2022

Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265Funder: Max...

Author Correction: Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation (Nature Immunology, (2019), 20, 3, (288-300), 10.1038/s41590-018-0298-5)

Zundler, Sebastian
Becker, Emily
Spocinska, Marta
Slawik, Monique
Parga-Vidal, Loreto
Stark, Regina
Wiendl, Maximilian
Atreya, Raja
Rath, Timo
Leppkes, Moritz
Hildner, Kai
López-Posadas, Rocío
Lukassen, S. ren
Ekici, Arif B.
Neufert, Clemens
Atreya, Imke
van Gisbergen, Klaas P. J. M.
Neurath, Markus F.

January 2019

In the version of this article initially published, a portion of the Acknowledgements section (“the ...

Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.

Taieb, Julien
Rivera, Fernando
Siena, Salvatore
Karthaus, Meinolf
Valladares-Ayerbes, Manuel
Gallego, Javier
Geissler, Michael
Koukakis, Reija
Demonty, Gaston
Peeters, Marc

January 2018

The authors would like to include the following changes in the published article

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells (Scientific Reports, (2017), 7, 1, (5898), 10.1038/s41598-017-05859-z)

AlShamaileh, H
Wang, T
Xiang, D
Yin, W
Tran, Ha Lien Phuong
Barrero, RA
Zhang, PZ
Li, Y
Kong, Lingxue
Liu, K
Zhou, SF
Hou, Y
Shigdar, Sarah
Duan, Wei

December 2020

An amendment to this paper has been published and can be accessed via a link at the top of the paper...

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments (Annals of Hematology, (2020), 99, 2, (277-282), 10.1007/s00277-019-03893-7)

Bari A.
Marcheselli R.
Sacchi S.
Re A.
Pagani C.
Tucci A.
Botto B.
Vitolo U.
Molinari A. L.
Puccini B.
Pulsoni A.
Santoro A.
Tani M.
Nassi L.
Meli E.
Pavone V.
Bonfichi M.
Evangelista A.
Gioia D.
Levis A.
Zinzani P.

January 2021

In the article entitled “The classic prognostic factors in advanced Hodgkin’s lymphoma patients are ...

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments (Annals of Hematology, (2020), 99, 2, (277-282), 10.1007/s00277-019-03893-7)

Bari A.
Marcheselli R.
Sacchi S.
Re A.
Pagani C.
Tucci A.
Botto B.
Vitolo U.
Molinari A. L.
Puccini B.
Pulsoni A.
Santoro A.
Tani M.
Nassi L.
Meli E.
Pavone V.
Bonfichi M.
Evangelista A.
Gioia D.
Levis A.
Zinzani P.

January 2021

In the article entitled “The classic prognostic factors in advanced Hodgkin’s lymphoma patients are ...

Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9)

April 2022

open12noAcknowledgements: This work was supported in part by Rigenerand srl and by Associazione Sost...

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Schaule, J.
Kroeze, S.G.C.
Blanck, O.
Stera, S.
Kahl, K.H.
Roeder, F.
Combs, S.E.
Kaul, D.
Claes, A.
Schymalla, M.M.
Adebahr, S.
Eckert, F.
Lohaus, F.
Abbasi-Senger, N.
Henke, G.
Szuecs, M.
Geier, M.
Sundahl, N.
Buergy, D.
Dummer, R.
Guckenberger, M.

January 2020

An amendment to this paper has been published and can be accessed via the original article

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Abstract

Extracted data

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Abstract

Extracted data

Related items

Related items